Back to Results
First PageMeta Content
Medicine / Clinical medicine / Autoimmune diseases / Biology / Mucinoses / RNA / Scleroderma / MicroRNA / Fibrosis / Mechanistic target of rapamycin / Systemic scleroderma / Scleromyositis


Technology Opportunity, Ref. No. UZNovel Pharmacological Treatment of Scleroderma This invention relates to a novel pharmacological treatment of scleroderma comprising the administration of miR-29.
Add to Reading List

Document Date: 2014-02-01 16:20:50


Open Document

File Size: 24,88 KB

Share Result on Facebook